BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 4811605)

  • 1. Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer.
    Hansen HJ; Snyder JJ; Miller E; Vandevoorde JP; Miller ON; Hines LR; Burns JJ
    Hum Pathol; 1974 Mar; 5(2):139-47. PubMed ID: 4811605
    [No Abstract]   [Full Text] [Related]  

  • 2. Current status of carcinoembryonic antigen assay.
    Chu TM
    Semin Nucl Med; 1975 Jul; 5(3):255-62. PubMed ID: 1154032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory monitoring and screening for cancer.
    Hobbs JR
    Lancet; 1974 Nov; 2(7892):1305-7. PubMed ID: 4139538
    [No Abstract]   [Full Text] [Related]  

  • 4. Application of immunohistochemical methods in the diagnosis of malignant disease.
    Imam A; Taylor CR
    Cancer Invest; 1985; 3(4):339-59. PubMed ID: 3896421
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis in suspected tumorous diseases in the aged].
    Pleissner I; Reitzig P
    Z Arztl Fortbild (Jena); 1984; 78(1):13-5. PubMed ID: 6711023
    [No Abstract]   [Full Text] [Related]  

  • 6. [Significance of blood carcinoembryonic antigen (CEA) in the diagnosis and follow-up of tumors of the stomach and large intestine].
    Lorusso D; Lacitignola S; Giorgio P; Sisto G
    Minerva Dietol Gastroenterol; 1984; 30(2):191-6. PubMed ID: 6472702
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical value of the plasma-CEA-concentrations in the primary diagnosis of malignoma of the digestive tract].
    Aver IO; Münch L; Epping J; Schmid L
    Z Gastroenterol Verh; 1976; (11):73-7. PubMed ID: 65868
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical significance of carcinoembryonic antigen (CEA) plasma concentration in the 1st diagnosis of digestive-tract malignomas].
    Auer IO; Münch L; Epping J; Schmid L
    Z Gastroenterol; 1977 Aug; 15(8):491-503. PubMed ID: 906599
    [No Abstract]   [Full Text] [Related]  

  • 9. [The delay in cancer diagnosis. Causes and significance].
    Hegemann G; Hoferichter J
    Munch Med Wochenschr; 1968 Feb; 110(7):377-83. PubMed ID: 5695056
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of CEA determinations in patients with cancer of the colon-rectum and the mammary gland in comparison to physiological states in connection with pregnancy.
    Lamerz R; Ruider H
    Bull Cancer; 1976; 63(4):575-86. PubMed ID: 1021185
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
    Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
    Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003
    [No Abstract]   [Full Text] [Related]  

  • 12. Carcinoembryonic antigen (CEA). A prospective clinical trail in patients with gastrointestinal cancer.
    Kjaer M; Fischerman K
    Scand J Gastroenterol Suppl; 1976; 37():99-106. PubMed ID: 1064149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CEA: an exam to be used in diagnostic laboratories or still only for research purposes? Current status].
    Aletti P; Marnini P
    Quad Sclavo Diagn; 1977 Sep; 13(3):331-49. PubMed ID: 565935
    [No Abstract]   [Full Text] [Related]  

  • 14. CEA as an adjunct in the diagnosis and prognosis of colorectal carcinoma.
    Martin E; Skivolocki W; Minton JP
    Rev Surg; 1975; 32(3):214-7. PubMed ID: 1135606
    [No Abstract]   [Full Text] [Related]  

  • 15. National Institutes of Health Consensus Development Conference Statement: CEA (carcinoembryonic antigen): its role as a marker in the management of cancer.
    N C Med J; 1981 Sep; 42(9):660-4. PubMed ID: 6946297
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with carcinoembryonic antigen (CEA) as a tumor marker.
    Perlin E
    Mil Med; 1981 Aug; 146(8):549-51. PubMed ID: 6793896
    [No Abstract]   [Full Text] [Related]  

  • 17. [Carcinoembryonic antigen (author's transl)].
    Yamaguchi N; Inoue H; Ogawa H; Ohomi H; Kimoto K; Machino M; Ikeuchi H; Takeuchi S; Hayashi K; Aoike A; Akasaka Y; Kawai K
    Nihon Shokakibyo Gakkai Zasshi; 1979 Jun; 76(6):1246-52. PubMed ID: 381734
    [No Abstract]   [Full Text] [Related]  

  • 18. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
    Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
    Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences with determining carcinoembryonic antigen in tumors of the digestive tract].
    Pelikán A
    Zentralbl Chir; 1986; 111(18):1113-8. PubMed ID: 3024422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal antibodies in the radionuclide diagnosis and therapy of tumors].
    Anokhin IuN; Dedenkov AN; Norets TA
    Med Radiol (Mosk); 1985 Jun; 30(6):72-8. PubMed ID: 3894856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.